| Abbott India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500488 |
NSE Symbol : ABBOTINDIA |
P/E(TTM) : 47.33 |
|
ISIN Demat : INE358A01014 |
Div & Yield% : 1.43 |
EPS(TTM) : 604.55 |
|
Book Value(₹) : 1,656.99 |
Market Cap(₹Cr) : 60,801.24 |
Face Value(₹) : 10.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 5,875.26 | 5,379.08 | 4,932.57 | 4,310.02 | 4,093.14 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 5,875.26 | 5,379.08 | 4,932.57 | 4,310.02 | 4,093.14 |
| Other Income | 248.27 | 154.15 | 83.16 | 80.90 | 114.39 |
| Stock Adjustments | -7.73 | -66.09 | 22.28 | 104.00 | -61.24 |
| Total Income | 6,115.80 | 5,467.14 | 5,038.01 | 4,494.92 | 4,146.29 |
| EXPENDITURE : | |||||
| Raw Materials | 3,212.88 | 2,908.97 | 2,679.49 | 2,494.92 | 2,254.39 |
| Power and Fuel Cost | 16.63 | 17.15 | 14.98 | 12.74 | 13.73 |
| Other Manufacturing Expenses | 126.47 | 79.99 | 59.82 | 49.66 | 49.84 |
| Selling and Administration Expenses | 429.89 | 467.74 | 459.18 | 366.98 | 400.27 |
| Miscellaneous Expenses | 51.98 | 69.92 | 80.15 | 75.61 | 81.11 |
| Employee Benefit Expenses | 576.58 | 563.59 | 579.46 | 492.65 | 476.11 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,701.37 | 1,359.78 | 1,164.93 | 1,002.36 | 870.84 |
| Interest | 12.45 | 15.99 | 19.10 | 18.28 | 8.53 |
| Gross Profit | 1,688.92 | 1,343.79 | 1,145.83 | 984.08 | 862.31 |
| Depreciation | 71.17 | 69.97 | 66.10 | 58.13 | 59.61 |
| Profit Before Tax | 1,617.75 | 1,273.82 | 1,079.73 | 925.95 | 802.70 |
| Current Tax | 415.46 | 325.60 | 281.16 | 239.05 | 208.29 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | 1.07 | -1.19 | -0.13 | -3.79 | 1.48 |
| Reported Net Profit | 1,201.22 | 949.41 | 798.70 | 690.69 | 592.93 |
| Extraordinary Items | 0.12 | -0.19 | - | -0.18 | -0.41 |
| Adjusted Net Profit | 1,201.10 | 949.60 | 798.70 | 690.87 | 593.34 |
| Adjustment below Net Profit | - | - | - | - | -35.51 |
| Profit/Loss Balance carried down | 2,428.51 | 2,158.40 | 2,023.93 | 1,933.54 | 1,573.53 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 810.72 | 679.30 | 664.23 | 600.30 | 197.41 |
| P & L Balance carried down | 2,819.01 | 2,428.51 | 2,158.40 | 2,023.93 | 1,933.54 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 4,100.00 | 3,250.00 | 2,750.00 | 2,750.00 | 2,500.00 |
| Dividend Per Share(Rs) | 410.00 | 325.00 | 275.00 | 275.00 | 250.00 |
| Earnings Per Share-Unit Curr | 565.28 | 446.78 | 375.86 | 325.03 | 279.03 |
| Earnings Per Share(Adj)-Unit Curr | 565.28 | 446.78 | 375.86 | 325.03 | 279.03 |
| Book Value | 1,740.65 | 1,500.49 | 1,326.96 | 1,224.55 | 1,144.33 |
| Book Value(Adj)-Unit Curr | 1,740.65 | 1,500.49 | 1,326.96 | 1,224.55 | 1,144.33 |